Search Medical Condition
Please enter condition
Please choose location

Heart Attack (Myocardial Infarction) Clinical Trials

A listing of Heart Attack (Myocardial Infarction) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (62) clinical trials

People with these conditions have a higher risk of heart attack or stroke in the future. Because we know who is at a greater risk, we want to take early steps to try to prevent a cardiovascular emergency. The Aleprevent clinical research study will look at whether an investigational medication ...

Phase N/A

Have you been told that you have or that you are at risk for developing Heart Disease? If you are 45 years of age or older and have high triglyceride levels, you may be eligible to participate in a clinical research study evaluating the safety and effectiveness of an investigational ...

Phase N/A

Announcing a new research study of nutritional supplements Specifically, the study will examine whether certain supplements can reduce readmission rates in adults >65 years of age who are hospitalized for the following diagnoses: Heart attack Heart failure COPD Pneumonia

Phase N/A

The THEMIS clinical research study is evaluating a study drug to see if it may help prevent heart attack and stroke in people with type 2 diabetes.

Phase N/A

Phase 3 Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Evaluation of the Efficacy, Safety, and Tolerability of a Research Medication in Reducing the Occurrence of Major Cardiovascular Events

Phase N/A

1. Background 1.1. Antiplatelet therapy after acute myocardial infarction Dual antiplatelet therapy with aspirin, combined with a P2Y12 receptor inhibitor, is a cornerstone of therapy for acute myocardial infarction (AMI). Treatment with clopidogrel in addition to aspirin resulted in a 20% reduction in major adverse cardiovascular events (MACE) when compared ...

Phase N/A

WHAT IS THE SPIRE PROGRAM? The SPIRE program is a series of clinical studies that is investigating a study drug in people who have high cholesterol. This study drug is being evaluated to understand its effects on bad cholesterol (LDL-C) and cardiovascular events such as heart attack or stroke. The ...

Phase

"THE VERTIS CV STUDY" Type 2 Diabetes Mellitus and Established Vascular Disease Merck and Pfizer Announce Two Pivotal Phase 3 Studies for Ertugliflozin, an Investigational SGLT-2 Inhibitor, Met Primary Endpoints, Showing Significant A1C Reductions in Patients with Type 2 Diabetes http://www.mercknewsroom.com/news-release/corporate-news/merck-and-pfizer-announce-two-pivotal-phase-3-studies-ertugliflozin-inve

Phase

Effects of Nicorandil on Cardiac Infarct Size in Patients With ST-segment Elevation Acute Myocardial Infarction

Study objective : To investiage whether nicorandil treatment reduce infarct size measured by cardiac MRI at 6 months after primary PCI Allocation : 1. Nicorandil arm : Recieve nicorandil 4 mg i.v. before undergoing PCI, additionall 2mg i.c. just before 1st ballooning, additionall 2mg i.c. just before stenting, After successful ...

Phase

Left Atrial Appendage Closure Compared to Standard Antiplatelet Therapy in Patients With AF Who Underwent PCI

This will be prospective randomized (1:1) open label pilot study. Patients with unstable angina and non-ST-elevation ACS and history of AF will be included in this study. After PCI and DES implantation TEE will be performed for assessing LAA anatomy and size eligible for left atrial appendage closure device implantation. ...

Phase